| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.0M | — | — |
| R&D Expense | $4.6M | +15.4% | +3.1% |
| SG&A Expense | $3.1M | +12.1% | +4.4% |
| Operating Income | -$7.7M | -14.1% | -3.6% |
| Pre-tax Income | -$7.6M | -14.6% | -6.2% |
| Income Tax | $8K | -13.4% | -30.7% |
| Net Income | -$7.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.9M | +37.0% | -19.0% |
| Current Assets | $16.6M | +34.6% | -27.1% |
| Total Assets | $20.1M | +28.4% | -20.1% |
| Current Liabilities | $10.9M | +8.4% | +65.3% |
| Total Liabilities | $11.8M | +7.6% | +55.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.9M | — | — |
| Capital Expenditures | $568K | — | — |
| Investing Cash Flow | -$568K | — | — |
| Financing Cash Flow | $11.7M | — | — |
| Free Cash Flow | -$13.5M | — | — |
| -6.1% |
| EPS (Basic) | -$0.24 | -9.1% | +0.0% |
| EPS (Diluted) | -$0.24 | -9.1% | +0.0% |
| $8.3M |
| +77.6% |
| -52.9% |